Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Optimizing lymphatic pumping to boost flu vaccine response in older or overweight adults

Official title: Optimizing Lymphatic Pumping for Influenza Vaccine Responses in Vulnerable Populations

Run by Lake Erie College of Osteopathic Medicine · NCT07786467 · Data updated 2026-11-12

This study tests whether a specific osteopathic manipulation technique can help people, especially older adults or those with higher body fat, produce a stronger antibody response to the seasonal influenza vaccine.

More No Disease or Condition is Being Studied trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorLake Erie College of Osteopathic Medicine
Academic / other
Locations1 site (Erie, Pennsylvania)
StatusRecruiting
StartedSeptember 2026
Main results expectedOctober 2027
Study endsOctober 2027
Registry record updatedSeptember 23, 2026
Trial IDNCT07786467 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older who are willing to receive both the influenza vaccine and osteopathic manipulative treatment.

Probably not a fit

Individuals who do not mount a stronger antibody response or who do not benefit from the osteopathic protocol may not experience improvement in vaccine response.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study will compare an osteopathic manipulative treatment protocol to a sham procedure to see if it enhances antibody titers after influenza vaccination. Participants are adults 18 and older who are willing to receive the vaccine and osteopathic manipulative treatment, including those who are older or have higher adiposity. The study focuses on immune responses in healthy volunteers without a specific disease being studied. It is conducted at Plaza 38 Medical Offices in Erie, Pennsylvania, led by Lake Erie College of Osteopathic Medicine.

Why it matters

Potential benefit: If successful, participants may achieve a stronger antibody response to the influenza vaccine, potentially improving protection against flu.

How similar studies have gone: Previous work in related osteopathic or manual therapies has shown mixed results; this study tests a specific protocol in a defined population and its success remains to be established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Willing to receive OMT
* Willing to receive influenza vaccine
* Older than 18 years of age

Exclusion Criteria:

* Younger than 18 years of age
* Pregnancy or lactation
* Unwilling to receive the influenza vaccine
* Unwilling to receive OMT
* Open wounds
* Bone fractures
* Moderate to severe osteoporosis
* Severe COPD
* Current/active infections
* Mononucleosis infection within past 6 months
* Liver cirrhosis
* Cancer or metastatic disease
* History of DVT, PE, or blood clotting disorder
* Individuals taking blood thinning medications, except aspirin
* Having a pacemaker or other thoracic medical devices

Where it's running

  • Plaza 38 Medical Offices
    Erie, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: David Duriancik, Ph.D. — Lake Erie College of Osteopathic Medicine
  • Study coordinator: David Duriancik, Ph.D.
  • Email: dduriancik@lecom.edu
  • Phone: 814-860-5139

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.